Cargando…
Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty
AIM: “Consensual ophthalmotonic reaction” refers to changes in intraocular pressure (IOP) in one eye, which is accompanied by a corresponding change in IOP in the contralateral eye. This study evaluates whether monocular administration of selective laser trabeculoplasty (SLT) leads to a consensual o...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385382/ https://www.ncbi.nlm.nih.gov/pubmed/36060042 http://dx.doi.org/10.5005/jp-journals-10078-1361 |
_version_ | 1784769580408766464 |
---|---|
author | Nassiri, Nariman Mei, Frank Tokko, Hassan Zeiter, John Syeda, Sarah Kim, Chaesik Swendris, Ronald Goyal, Anju Veld, Elise In'T Mas-Ramirez, Alma Rana, Sonia W Juzych, Mark S Hughes, Bret A |
author_facet | Nassiri, Nariman Mei, Frank Tokko, Hassan Zeiter, John Syeda, Sarah Kim, Chaesik Swendris, Ronald Goyal, Anju Veld, Elise In'T Mas-Ramirez, Alma Rana, Sonia W Juzych, Mark S Hughes, Bret A |
author_sort | Nassiri, Nariman |
collection | PubMed |
description | AIM: “Consensual ophthalmotonic reaction” refers to changes in intraocular pressure (IOP) in one eye, which is accompanied by a corresponding change in IOP in the contralateral eye. This study evaluates whether monocular administration of selective laser trabeculoplasty (SLT) leads to a consensual ophthalmotonic reaction and how long this effect lasts. MATERIALS AND METHODS: A retrospective chart review was performed on patients receiving SLT at Kresge Eye Institute in Detroit, MI, from January 2015 to August 2016. Patients were excluded if they had previous history of glaucoma incisional and/or laser procedures; required additional laser trabeculoplasty; had glaucoma medication changes during the follow-up period; experienced no decrease in IOP during the follow-up period; or had a diagnosis of angle closure on gonioscopy. Various demographic, clinical, and surgical data were collected. IOP measurements were collected at baseline and postoperatively at 1–3 months, 4–9 months, and 12–15 months. RESULTS: At all follow-up periods, the IOP of the treated eye was decreased from baseline IOP (p ≤ 0.05, paired t-test). For the fellow eye, there was a statistically significantly decrease from baseline up to the 4–9 months follow-up period (p ≤ 0.05, paired t-test). Linear regression analysis of the percent reduction in IOP from baseline in the SLT-treated eye with the fellow eye shows a mild correlation at all-time points: R(2) = 0.284 (p < 0.001) at 1–3 months; R(2) = 0.348 (p < 0.001) at 4–9 months; R(2) = 0.118 (p = 0.054) at 12–15 months. CONCLUSION: This study showed that monocular administration of SLT results in a consensual ophthalmotonic reaction. The consensual ophthalmotonic reaction appears to last for up to 4–9 months. CLINICAL SIGNIFICANCE: Therefore, although SLT does lead to a consensual ophthalmotonic reaction, monocular administration of SLT is not a reliable method of long-term IOP control for the contralateral non-SLT-treated eye. HOW TO CITE THIS ARTICLE: Nassiri N, Mei F, Tokko H, et al. Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty. J Curr Glaucoma Pract 2022;16(1):36–40. |
format | Online Article Text |
id | pubmed-9385382 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Jaypee Brothers Medical Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-93853822022-09-02 Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty Nassiri, Nariman Mei, Frank Tokko, Hassan Zeiter, John Syeda, Sarah Kim, Chaesik Swendris, Ronald Goyal, Anju Veld, Elise In'T Mas-Ramirez, Alma Rana, Sonia W Juzych, Mark S Hughes, Bret A J Curr Glaucoma Pract Original Research AIM: “Consensual ophthalmotonic reaction” refers to changes in intraocular pressure (IOP) in one eye, which is accompanied by a corresponding change in IOP in the contralateral eye. This study evaluates whether monocular administration of selective laser trabeculoplasty (SLT) leads to a consensual ophthalmotonic reaction and how long this effect lasts. MATERIALS AND METHODS: A retrospective chart review was performed on patients receiving SLT at Kresge Eye Institute in Detroit, MI, from January 2015 to August 2016. Patients were excluded if they had previous history of glaucoma incisional and/or laser procedures; required additional laser trabeculoplasty; had glaucoma medication changes during the follow-up period; experienced no decrease in IOP during the follow-up period; or had a diagnosis of angle closure on gonioscopy. Various demographic, clinical, and surgical data were collected. IOP measurements were collected at baseline and postoperatively at 1–3 months, 4–9 months, and 12–15 months. RESULTS: At all follow-up periods, the IOP of the treated eye was decreased from baseline IOP (p ≤ 0.05, paired t-test). For the fellow eye, there was a statistically significantly decrease from baseline up to the 4–9 months follow-up period (p ≤ 0.05, paired t-test). Linear regression analysis of the percent reduction in IOP from baseline in the SLT-treated eye with the fellow eye shows a mild correlation at all-time points: R(2) = 0.284 (p < 0.001) at 1–3 months; R(2) = 0.348 (p < 0.001) at 4–9 months; R(2) = 0.118 (p = 0.054) at 12–15 months. CONCLUSION: This study showed that monocular administration of SLT results in a consensual ophthalmotonic reaction. The consensual ophthalmotonic reaction appears to last for up to 4–9 months. CLINICAL SIGNIFICANCE: Therefore, although SLT does lead to a consensual ophthalmotonic reaction, monocular administration of SLT is not a reliable method of long-term IOP control for the contralateral non-SLT-treated eye. HOW TO CITE THIS ARTICLE: Nassiri N, Mei F, Tokko H, et al. Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty. J Curr Glaucoma Pract 2022;16(1):36–40. Jaypee Brothers Medical Publishers 2022 /pmc/articles/PMC9385382/ /pubmed/36060042 http://dx.doi.org/10.5005/jp-journals-10078-1361 Text en Copyright © 2022; The Author(s). https://creativecommons.org/licenses/by-nc/4.0/© The Author(s). 2022 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Original Research Nassiri, Nariman Mei, Frank Tokko, Hassan Zeiter, John Syeda, Sarah Kim, Chaesik Swendris, Ronald Goyal, Anju Veld, Elise In'T Mas-Ramirez, Alma Rana, Sonia W Juzych, Mark S Hughes, Bret A Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty |
title | Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty |
title_full | Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty |
title_fullStr | Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty |
title_full_unstemmed | Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty |
title_short | Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty |
title_sort | consensual ophthalmotonic reaction following selective laser trabeculoplasty |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385382/ https://www.ncbi.nlm.nih.gov/pubmed/36060042 http://dx.doi.org/10.5005/jp-journals-10078-1361 |
work_keys_str_mv | AT nassirinariman consensualophthalmotonicreactionfollowingselectivelasertrabeculoplasty AT meifrank consensualophthalmotonicreactionfollowingselectivelasertrabeculoplasty AT tokkohassan consensualophthalmotonicreactionfollowingselectivelasertrabeculoplasty AT zeiterjohn consensualophthalmotonicreactionfollowingselectivelasertrabeculoplasty AT syedasarah consensualophthalmotonicreactionfollowingselectivelasertrabeculoplasty AT kimchaesik consensualophthalmotonicreactionfollowingselectivelasertrabeculoplasty AT swendrisronald consensualophthalmotonicreactionfollowingselectivelasertrabeculoplasty AT goyalanju consensualophthalmotonicreactionfollowingselectivelasertrabeculoplasty AT veldeliseint consensualophthalmotonicreactionfollowingselectivelasertrabeculoplasty AT masramirezalma consensualophthalmotonicreactionfollowingselectivelasertrabeculoplasty AT ranasoniaw consensualophthalmotonicreactionfollowingselectivelasertrabeculoplasty AT juzychmarks consensualophthalmotonicreactionfollowingselectivelasertrabeculoplasty AT hughesbreta consensualophthalmotonicreactionfollowingselectivelasertrabeculoplasty |